Dual incretin pharmacology
Receptor-selectivity and signaling-bias studies compare its GIP and GLP-1 activity to single agonists.
BOGO Dual GIP / GLP-1 receptor agonist · LY3298176
Every two vials of the same size count as one paid and one free. Applied automatically; nothing to enter.
2 vials total · 1 paid + 1 free · free U.S. shipping · ships same day before 2 pm ET
GLP-2 (TR) is a 39-amino-acid synthetic peptide with a C20 fatty-diacid side chain that binds both GIP and GLP-1 receptors. It is one of the most studied dual incretin agonists in the literature.
Published findings for this compound are predominantly preclinical. Results from cell or animal models do not establish safety, effectiveness or benefit in humans, and nothing on this page is a recommendation for any use other than laboratory research.
Receptor-selectivity and signaling-bias studies compare its GIP and GLP-1 activity to single agonists.
Rodent studies have assessed glucose tolerance, lipid handling and adiposity markers.
Albumin binding from the fatty-diacid moiety has been characterized in preclinical PK work.
Research areas reflect topics in the published literature. They are not claims of demonstrated effects or expected outcomes.
Store lyophilized at -20°C (-4°F), protected from light. After reconstitution, keep at 2–8°C and use within 7 days.
Reconstitute with bacteriostatic water added slowly down the inside wall of the vial; swirl gently and never shake. See the reconstitution and storage guide for a step-by-step bench procedure.
GIP / GLP-1 / glucagon triple receptor agonist · LY3437943
GLP-2 (TR) is supplied strictly for in-vitro laboratory research. It is not approved by the FDA for any use, is not a dietary supplement, and is not for human or animal consumption. Purchasers must be 21 or older.
Newsletter
New compounds, fresh lots and members-only offers, straight to your inbox.
Materials on this site are sold for laboratory research only and are not for human or animal use. You must be at least 21 years old to enter.
By entering you accept our terms and research-use policy.
Original laboratory report served by AuthentiChain. If the preview doesn't render in your browser, use "Open in new tab".